Literature DB >> 3713185

Prognostic factors of esophageal carcinoma: univariate and multivariate analyses.

K Sugimachi, H Matsuura, H Kai, T Kanematsu, K Inokuchi, K Jingu.   

Abstract

The correlation of 5-year survival rate with various clinical and histopathological factors was studied using univariate and multiple analyses of 128 patients who had undergone resection for esophageal carcinoma between 1965 and 1978 in the Department of Surgery, Kyushu University Hospital. The depth of penetration, lymph node metastasis, lymphatic or vascular invasion, and INF had a significant correlation with 5-year survival in the univariate analysis; however, only depth of penetration and lymph node metastasis were prognostic factors with a significant difference, in the multivariate analysis. In 55 patients in whom the cell nuclear DNA content had been determined, the DNA pattern was the greatest prognostic factor (p less than 0.01), in multivariate analysis. We propose that the DNA distribution in the malignant cells should be examined as a most pertinent prognostic factor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713185     DOI: 10.1002/jso.2930310207

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  11 in total

1.  Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy.

Authors:  R C Karl; R Schreiber; D Boulware; S Baker; D Coppola
Journal:  Ann Surg       Date:  2000-05       Impact factor: 12.969

2.  Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis.

Authors:  Jingxun Wu; Xuan Wu; Wenhua Liang; Chunling Chen; Lingling Zheng; Hanxiang An
Journal:  Tumour Biol       Date:  2013-12-11

3.  New invasive patterns as a prognostic factor for superficial esophageal cancer.

Authors:  Eisuke Ito; Soji Ozawa; Hiroshi Kijima; Akihito Kazuno; Takayuki Nishi; Osamu Chino; Hideo Shimada; Makiko Tanaka; Shigeaki Inoue; Sadaki Inokuchi; Hiroyasu Makuuchi
Journal:  J Gastroenterol       Date:  2012-05-12       Impact factor: 7.527

4.  Prognostic value of lymphovascular invasion in patients with esophageal squamous cell carcinoma.

Authors:  Yi-Min Gu; Yu-Shang Yang; Wei-Peng Hu; Wen-Ping Wang; Yong Yuan; Long-Qi Chen
Journal:  Ann Transl Med       Date:  2019-06

5.  Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.

Authors:  Mitsuhiro Shirakawa; Yoshiyuki Fujiwara; Yurika Sugita; Jeong-Ho Moon; Shuji Takiguchi; Kiyokazu Nakajima; Hiroshi Miyata; Makoto Yamasaki; Masaki Mori; Yuichiro Doki
Journal:  Oncol Rep       Date:  2011-12-22       Impact factor: 3.906

6.  Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA.

Authors:  M Kano; Y Shimada; J Kaganoi; T Sakurai; Z Li; F Sato; G Watanabe; M Imamura
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

7.  Factors affecting the survival of patients with oesophageal carcinoma under radiotherapy in the north of Iran.

Authors:  K O Hajian-Tilaki
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

8.  Prognostic significance of the pN classification supplemented by vascular invasion for esophageal squamous cell carcinoma.

Authors:  Chong-Mei Zhu; Yi-Hong Ling; Shao-Yan Xi; Rong-Zhen Luo; Jie-Wei Chen; Jing-Ping Yun; Dan Xie; Mu-Yan Cai
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

9.  Prognostic significance of the pN classification supplemented by body mass index for esophageal squamous cell carcinoma.

Authors:  Feixiang Wang; Hao Duan; Muyan Cai; Jianhua Fu; Guowei Ma; Han Yang; Zihui Tan; Ronggui Hu; Peng Lin; Xu Zhang
Journal:  Thorac Cancer       Date:  2015-04-15       Impact factor: 3.500

10.  Lymphovascular invasion as an independent prognostic indicator in radically resected thoracic esophageal squamous cell carcinoma.

Authors:  Zhen Wang; Peng Chen; Feng Wang; Liyan Lin; Shuoyan Liu
Journal:  Thorac Cancer       Date:  2018-11-28       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.